New US Food and Drug Administration Approvals Decrease Generic Flucytosine Costs

Radha Rajasingham; David R. Boulware

doi:10.1093/cid/ciz037

New US Food and Drug Administration Approvals Decrease Generic Flucytosine Costs

Radha Rajasingham, David R. Boulware

Medicine - Infectious Disease and International Medicine

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	732
Number of pages	1
Journal	Clinical Infectious Diseases
Volume	69
Issue number	4
DOIs	https://doi.org/10.1093/cid/ciz037
State	Published - Aug 15 2019

Bibliographical note

Funding Information:
Financial support. This work was supported by the National Institute of Allergy and Infectious Diseases (U01AI125003, K23AI138851).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1093/cid/ciz037

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669281

Find It

Find It at U of M Libraries

Cite this

@article{acea3397e1f7448aa6bd9147b20be9a2,

title = "New US Food and Drug Administration Approvals Decrease Generic Flucytosine Costs",

author = "Radha Rajasingham and Boulware, {David R.}",

note = "Funding Information: Financial support. This work was supported by the National Institute of Allergy and Infectious Diseases (U01AI125003, K23AI138851).",

year = "2019",

month = aug,

day = "15",

doi = "10.1093/cid/ciz037",

language = "English (US)",

volume = "69",

pages = "732",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - New US Food and Drug Administration Approvals Decrease Generic Flucytosine Costs

AU - Rajasingham, Radha

AU - Boulware, David R.

N1 - Funding Information: Financial support. This work was supported by the National Institute of Allergy and Infectious Diseases (U01AI125003, K23AI138851).

PY - 2019/8/15

Y1 - 2019/8/15

UR - http://www.scopus.com/inward/record.url?scp=85078564382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85078564382&partnerID=8YFLogxK

U2 - 10.1093/cid/ciz037

DO - 10.1093/cid/ciz037

M3 - Letter

C2 - 30698690

AN - SCOPUS:85078564382

SN - 1058-4838

VL - 69

SP - 732

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 4

ER -

New US Food and Drug Administration Approvals Decrease Generic Flucytosine Costs

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Cite this